Congress sets aside a large pot of pork-barrel funds for research projects in 2012, but not nearly as much as seen in pre-recession years.
The Scientist
Most Recent
During development, the cells of an embryo change their pattern of gene expression, which allows them to detach from their original location and migrate to another part of the embryo, where the pattern changes again to allow formation of a new organ.
A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.
Choosing to work in industry does not preclude a return to academe. But the move back takes some planning and finesse.
The NIH plans an extra layer of review for scientists with at least $1.5 million in existing grants.
Graduate students ask for more federal research support.
GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
Experts and the American public worry that the country is at risk of losing its global leadership position in scientific research.
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
